A new study reveals that a gene-editing drug has successfully lowered harmful cholesterol levels by <strong>62%</strong> in a small group of <strong>35 participants</strong>. These promising results could lead to new treatments for heart disease.
Biogen has announced its progress in developing an experimental drug for Alzheimer’s disease, moving to the final stage of clinical trials despite previous disappointing results. The data suggests that the treatment reduces tau protein levels and slows cognitive decline.
Researchers have unveiled an innovative drug that stimulates the growth of natural teeth, providing a potential alternative to artificial implants. This development marks a significant advancement in dentistry aimed at improving the quality of life for patients who have lost their teeth.
Research in France has announced the development of a preventive drug that promises to open new horizons in combating respiratory allergies. This drug aims to reprogram the immune response to allergens, providing individuals suffering from spring allergies a greater chance to overcome bothersome symptoms.
Recent studies have shown the success of an innovative drug in increasing the average lifespan of patients with advanced pancreatic cancer, surpassing traditional chemotherapy treatments. These findings represent a new ray of hope in the fight against this deadly disease.
Researchers at the Massey Comprehensive Cancer Center have developed a new drug aimed at preventing the spread of prostate cancer to the bones, potentially changing treatment approaches for this serious disease affecting millions of men worldwide.